The FDA warned that some Ritz products may have been mislabeled as cheese sandwiches instead of peanut butter ones.

Obesity and body mass index (BMI) are not associated with suboptimal bowel preparation for colonoscopy with low-volume agents, according to study results published in Digestive Diseases and Sciences.

Combination therapy with cagrilintide and semaglutide vs cagrilintide alone, semaglutide alone, and placebo is superior for improving weight loss results.

Biliary atresia in children is associated with neurodevelopmental delays, including communication, motor, and daily living skills.

A growing number of women with chronic inflammatory diseases are continuing to use TNF inhibitors throughout pregnancy.

New Mexico Piñon Coffee's Dark Pinon Single Serve Cups were recalled due to a risk of ink contamination in the coffee.

Tumor necrosis factor inhibitor use in patients with IMIDs did not increase the risk of de novo heart failure or worsen existing heart failure.

While the efficacy of TEM is higher than ESD for removing rectal neuroendocrine tumors, TEM has a higher recurrence rate.

The FDA, HHS, and USDA seek to create a federally recognized definition of ultra-processed foods to add consistency in research and policy.

The ABTECT clinical program included the randomized, double-blind, placebo-controlled phase 3 ABTECT-1 and ABTECT-2 trials.

Higher cumulative exposure to uric acid is independently and dose-dependently associated with an increased risk for MASLD. Cumulative uric acid (UA) exposure is an independent risk factor for ...

CagriSema vs placebo was associated with significant weight loss among adults with overweight or obesity with or without type 2 diabetes.